Skip to main content
Screener/Healthcare/Biotechnology

VNDA — Vanda Pharmaceuticals Inc.

NASDAQ
$7.08-0.03 (-0.35%)
Small CapUnder $10Healthcare
$3.81
$9.94
$6.98
$7.17
EPS (TTM)$-3.73
P/E Ratio-1.83
Dividend Yield—
Market Cap$407.3M
Volume570K
Prev Close$7.10
Revenue & Operating Income
Revenue
Operating Income
Net Income
Positive
Negative
Free Cash Flow
Positive
Negative
Gross Profit & Operating Expenses
Gross Profit
Operating Expenses
Earnings Per Share
Positive
Negative
Balance Sheet
Total Assets
Total Liabilities
Cash & Equivalents
Cash & Equivalents
Shares Outstanding
Shares Outstanding
Margins
Gross Margin
Operating Margin
Net Margin

Quarterly Results

QuarterRevenueNet IncomeEPSGross MarginNet Margin
Q4 '25$57.2M-$141.2M$-2.3993.3%-246.8%
Q3 '25$56.3M-$22.6M$-0.3894.7%-40.1%
Q2 '25$52.6M-$27.2M$-0.4691.5%-51.7%
Q1 '25$50.0M-$29.5M$-0.5093.0%-58.9%
Q4 '24$53.2M-$4.9M$-0.0895.1%-9.2%
Q3 '24$47.7M-$5.3M$-0.0994.6%-11.2%
Q2 '24$50.5M-$4.5M$-0.0891.1%-9.0%
Q1 '24$47.5M-$4.1M$-0.0788.5%-8.7%
Get Your Daily Market Recap